Skip to main content

Advertisement

Log in

Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

Colorectal cancer (CRC) remains an important public health problem in the world. Long noncoding RNA (lncRNA) is an RNA molecular that is longer than 200 nucleotides and cannot be translated into a protein. Recent studies have shown that lncRNAs play important roles in carcinogenesis and cancer metastasis. The aim of this study was to evaluate the expression and biological role of lncRNA maternally expressed gene 3 (MEG3) in colorectal cancer. Quantitative real-time-PCR (qRT-PCR) was performed to investigate the expression of MEG3 in tumor tissues and corresponding nontumor colorectal tissues from 62 patients. The lower expression of MEG3 was remarkably correlated with low histological grade, deep tumor invasion, and advanced tumor node metastasis (TNM) stage. Multivariate analyses revealed that MEG3 expression served as an independent predictor for overall survival. Further experiments revealed that overexpressed MEG3 significantly inhibited CRC cell proliferation both in vitro and in vivo. In conclusion, our study demonstrated that MEG3 is involved in the development and progression of colorectal cancer by regulating cell proliferation and shows that MEG3 may be a potential diagnostic and prognostic target in patients with colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.

    Article  PubMed  Google Scholar 

  2. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–73.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21:354–61.

    Article  CAS  PubMed  Google Scholar 

  4. Mattick JS, Taft RJ, Faulkner GJ. A global view of genomic information—moving beyond the gene and the master regulator. Trends Genet. 2010;26:21–8.

    Article  CAS  PubMed  Google Scholar 

  5. Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen X, et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res. 2013;41:D983–986.

    Article  CAS  PubMed  Google Scholar 

  6. Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011;71:3–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Benetatos L, Vartholomatos G, Hatzimichael E. Meg3 imprinted gene contribution in tumorigenesis. Int J Cancer. 2011;129:773–9.

    Article  CAS  PubMed  Google Scholar 

  8. Zhou Y, Zhang X, Klibanski A. Meg3 noncoding Rna: a tumor suppressor. J Mol Endocrinol. 2012;48:R45–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Schuster-Gossler K, Bilinski P, Sado T, Ferguson-Smith A, Gossler A. The mouse gtl2 gene is differentially expressed during embryonic development, encodes multiple alternatively spliced transcripts, and may act as an RNA. Dev Dyn. 1998;212:214–28.

    Article  CAS  PubMed  Google Scholar 

  10. da Rocha ST, Edwards CA, Ito M, Ogata T, Ferguson-Smith AC. Genomic imprinting at the mammalian dlk1-dio3 domain. Trends Genet. 2008;24:306–16.

    Article  PubMed  Google Scholar 

  11. Wang P, Ren Z, Sun P. Overexpression of the long non-coding RNA meg3 impairs in vitro glioma cell proliferation. J Cell Biochem. 2012;113:1868–74.

    Article  CAS  PubMed  Google Scholar 

  12. Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, et al. Loss of imprinting and allelic switching at the dlk1-meg3 locus in human hepatocellular carcinoma. PLoS One. 2012;7:e49462.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ying L, Huang Y, Chen H, Wang Y, Xia L, Chen Y, et al. Downregulated meg3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst. 2013;9:407–11.

    Article  CAS  PubMed  Google Scholar 

  14. Balik V, Srovnal J, Sulla I, Kalita O, Foltanova T, Vaverka M, et al. Meg3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas. J Neurooncol. 2013;112:1–8.

    Article  CAS  PubMed  Google Scholar 

  15. Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, et al. A pituitary-derived meg3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab. 2003;88:5119–26.

    Article  CAS  PubMed  Google Scholar 

  16. Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y, et al. Maternally expressed gene 3 (meg3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology. 2010;151:939–47.

    Article  CAS  PubMed  Google Scholar 

  17. Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, et al. Activation of p53 by meg3 non-coding RNA. J Biol Chem. 2007;282:24731–42.

    Article  CAS  PubMed  Google Scholar 

  18. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA hotair reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, et al. Long non-coding RNA anril is required for the prc2 recruitment to and silencing of p15(ink4b) tumor suppressor gene. Oncogene. 2011;30:1956–62.

    Article  CAS  PubMed  Google Scholar 

  20. Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, et al. Tgf-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res. 2014;20:1531–41.

    Article  CAS  PubMed  Google Scholar 

  21. Prensner JR, Chen W, Iyer MK, Cao Q, Ma T, Han S, et al. Pcat-1, a long noncoding RNA, regulates brca2 and controls homologous recombination in cancer. Cancer Res. 2014;74:1651–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Geng YJ, Xie SL, Li Q, Ma J, Wang GY. Large intervening non-coding RNA hotair is associated with hepatocellular carcinoma progression. J Int Med Res. 2011;39:2119–28.

    Article  CAS  PubMed  Google Scholar 

  23. Niinuma T, Suzuki H, Nojima M, Nosho K, Yamamoto H, Takamaru H, et al. Upregulation of mir-196a and hotair drive malignant character in gastrointestinal stromal tumors. Cancer Res. 2012;72:1126–36.

    Article  CAS  PubMed  Google Scholar 

  24. Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, et al. Long noncoding RNA hotair regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011;71:6320–6.

    Article  CAS  PubMed  Google Scholar 

  25. Zhang EB, Kong R, Yin DD, You LH, Sun M, Han L, et al. Long noncoding RNA anril indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of mir-99a/mir-449a. Oncotarget. 2014;5:2276–92.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Yin D, He X, Zhang E, Kong R, De W, Zhang Z. Long noncoding RNA gas5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol. 2014;31:253.

    Article  PubMed  Google Scholar 

  27. Khaitan D, Dinger ME, Mazar J, Crawford J, Smith MA, Mattick JS, et al. The melanoma-upregulated long noncoding RNA spry4-it1 modulates apoptosis and invasion. Cancer Res. 2011;71:3852–62.

    Article  CAS  PubMed  Google Scholar 

  28. Reis EM, Verjovski-Almeida S. Perspectives of long non-coding RNAs in cancer diagnostics. Front Genet. 2012;3:32.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han Z, Sui H, Tang Y, Wang Y, Liu N, Ren J, Hou F, Li Q. Long non-coding rna malat1 promotes tumour growth and metastasis in colorectal cancer through binding to sfpq and releasing oncogene ptbp2 from sfpq/ptbp2 complex. Br J Cancer. 2014.

  30. Han Y, Yang YN, Yuan HH, Zhang TT, Sui H, Wei XL, et al. Uca1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology. 2014;46:396–401.

    Article  CAS  PubMed  Google Scholar 

  31. Guo Q, Zhao Y, Chen J, Hu J, Wang S, Zhang D, et al. Braf-activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition. Oncol Lett. 2014;8:869–75.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zhi-hong Zhang or Ren-hua Guo.

Additional information

Dan-dan Yin and Zhi-jun Liu contributed equally to this work and should be regarded as joint first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yin, Dd., Liu, Zj., Zhang, E. et al. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Tumor Biol. 36, 4851–4859 (2015). https://doi.org/10.1007/s13277-015-3139-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3139-2

Keywords

Navigation